Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates

Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates

Abstract Triple negative breast cancer (TNBC) accounts for about a fifth of all breast cancers and includes a diverse group of cancers. The heterogeneity of TNBC and the lack of target receptors on the cell surface make it difficult to develop specific therapeutic treatments. These aspects cause the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gloria Bertoli, Claudia Cava, Fabio Corsi, Francesca Piccotti, Cristina Martelli, Luisa Ottobrini, Valentina Vaira, Isabella Castiglioni
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/55a1477ce51945d6b0c6006989afd3e2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares